T O'Reilly

Author PubWeight™ 40.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 1994 3.50
2 PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 2000 3.02
3 PKC412--a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug Des 2000 1.63
4 A rat model of bone cancer pain. Pain 2002 1.61
5 Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4. J Natl Cancer Inst 2001 1.59
6 Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity. Biochim Biophys Acta 2000 1.40
7 Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res 2000 1.39
8 Tyrosine kinase inhibitors: from rational design to clinical trials. Med Res Rev 2001 1.33
9 Part time work: one year's job share in Bristol. Br Med J (Clin Res Ed) 1984 1.33
10 Porcine haemophili and actinobacilli: characterization by means of API test strips and possible taxonomic implications. Can J Microbiol 1984 1.21
11 Significance of V-factor dependency in the taxonomy of Haemophilus species and related organisms. Int J Syst Bacteriol 1990 1.10
12 Effects of cultural conditions on protease production by Aeromonas hydrophila. Appl Environ Microbiol 1983 0.99
13 Defining the metabolic and growth responses of porcine haemophili to exogenous pyridine nucleotides and precursors. J Gen Microbiol 1986 0.95
14 Animal models in the evaluation of antimicrobial agents. Antimicrob Agents Chemother 1991 0.93
15 Pyridine nucleotide metabolism by extracts derived from Haemophilus parasuis and H. pleuropneumoniae. Can J Microbiol 1986 0.90
16 The scid mouse as an experimental model for the evaluation of anti-Pneumocystis carinii therapy. J Antimicrob Chemother 1995 0.88
17 Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agent. Pharmacol Ther 1999 0.88
18 Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits. Infect Immun 2000 0.85
19 Intraoperative sonographic localization of breast masses: success with specimen sonography and surgical bed sonography to confirm excision. J Ultrasound Med 2001 0.85
20 Measurement of total bile acids in gastric juice. J Clin Pathol 1984 0.85
21 Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect Immun 1997 0.84
22 Porphyrin ring source can alter the outer membrane protein profile of non-typable Haemophilus influenzae. J Med Microbiol 1990 0.83
23 Rat model of chronic lung infections caused by non-typable Haemophilus influenzae. J Med Microbiol 1991 0.83
24 Tryptone-yeast extract broth as a culture medium for Haemophilus pleuropneumoniae and Haemophilus parasuis to be used as challenge inocula. Can J Vet Res 1986 0.81
25 Efficacy of antimicrobial agent treatment in relation to treatment regimen: experimental models and clinical evaluation. J Antimicrob Chemother 1993 0.81
26 In vivo metabolism of epothilone B in tumor-bearing nude mice: identification of three new epothilone B metabolites by capillary high-pressure liquid chromatography/mass spectrometry/tandem mass spectrometry. Rapid Commun Mass Spectrom 2001 0.79
27 Chemical burns. A ten-year experience. Am Surg 1987 0.78
28 Dexamethasone treatment of lipopolysaccharide-induced meningitis in rabbits that mimics magnification of inflammation following antibiotic therapy. J Med Microbiol 1995 0.78
29 Effect of combination therapy of rifampicin and azithromycin on TNF levels during a rat model of chronic osteomyelitis. J Antimicrob Chemother 1997 0.78
30 Animal models as predictors of the safety and efficacy of antibiotics. Eur J Clin Microbiol Infect Dis 1990 0.78
31 Sulfa resistance in mouse-derived Pneumocystis carinii. J Eukaryot Microbiol 1996 0.77
32 Comparison of the spectrophotometric and high-performance liquid chromatographic analysis of indocyanine green in estimating systemic clearance in patients with chronic liver disease. J Chromatogr 1987 0.77
33 A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs. Br J Cancer 2003 0.77
34 Isolation and in-vitro and in-vivo characterisation of a mutant of Pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem. J Antimicrob Chemother 1994 0.77
35 Experimental rabbit model of meningitis produced by Haemophilus influenzae serotype c. J Med Microbiol 1992 0.76
36 (99m)Tc-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model. Nucl Med Commun 2001 0.75
37 Endogenous potentials evoked in simple cognitive tasks: scalp topography. Int J Neurosci 1987 0.75
38 Maintenance of intestinal epithelium structural integrity and mucosal leukocytes during chemotherapy by oral administration of muramyl tripeptide phosphatidylethanolamine. Cancer Biother Radiopharm 1996 0.75
39 Aggressive angiomyxoma. Ir Med J 1999 0.75
40 Remarks on the screening of antibiotics for antibacterial activity. Eur J Clin Microbiol Infect Dis 1990 0.75
41 Pregnant athletes: a summary review of the legal issues. J Sci Med Sport 2002 0.75
42 An unusual case of Capgras syndrome: the psychiatric ward as a stage. Psychiatr J Univ Ott 1990 0.75
43 Unique chemical reactivity of His-21 of CRM-197, a mutated diphtheria toxin. FEBS Lett 1998 0.75
44 A combined regimen for the prophylaxis of Curling's ulcer. Am Surg 1987 0.75
45 The effect of calcium channel blockade with nifedipine on splanchnic and systemic haemodynamics in cirrhosis. Aliment Pharmacol Ther 1987 0.75